SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: EyeDrMike who wrote (5639)2/24/1998 8:40:00 AM
From: Edderd  Read Replies (2) of 23519
 
Mike, Those are nice observations and categories of patients but not reality. Most of the time the doc is not going to be able to make that critical determination that this patient cannot be treated with Viagra. How would he determine this? We don't have any contraindications listed yet and it seems to be quite safe on preliminary reports. it's discussed at every meeting. Scenario #2 is however the saving grace of MUSE. It will probably take 4 to 8 doses before the patients will give it up and look elsewhere. My guess is 1 to 2 months. Don't forget there is a huge placebo class in this group who will swear by Viagra and boost it's image for quite a while. All IMHO Ed
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News